DexCom: Revenue Up, EPS Misses Mark
The quarter reflected steady revenue growth but underscored challenges in profit conversion, as seen in declining operating ...
Analyst Cautiously Optimistic On DexCom As Competitive Pressures Loom
DexCom reported Q4 revenue of $1.11 billion, surpassing estimates. The company reaffirmed its 2025 outlook while analysts ...
Dexcom (DXCM) Gets a Buy from Stifel Nicolaus
Stifel Nicolaus analyst Mathew Blackman reiterated a Buy rating on Dexcom (DXCM – Research Report) today and set a price target of $100.00. The ...
Is DexCom, Inc. (DXCM) the Best Medical Device Stock to Buy?
We recently published a list of the 10 Best Medical Device Stocks To Buy According to Hedge Funds. In this article, we are ...
Stratos Wealth Partners LTD. Purchases New Stake in DexCom, Inc. (NASDAQ:DXCM)
Stratos Wealth Partners LTD. purchased a new stake in DexCom, Inc. (NASDAQ:DXCM – Free Report) in the fourth quarter, HoldingsChannel.com reports. The fund purchased 2,583 shares of the medical device ...
Piper Sandler Reaffirms Their Buy Rating on Dexcom (DXCM)
In a report released today, Matthew O’Brien from Piper Sandler maintained a Buy rating on Dexcom (DXCM – Research Report), with a price target ...
Should You Buy DexCom Stock Before Feb. 13?
DexCom (NASDAQ: DXCM) is a healthcare company that makes continuous glucose monitoring (CGM) devices, which help people track ...